MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease
Sriram Balusu(Ghent University), Bart De Strooper(VIB-KU Leuven Center for Brain & Disease Research), Dries T’Syen(VIB-KU Leuven Center for Brain & Disease Research), Lutgarde Serneels(VIB-KU Leuven Center for Brain & Disease Research), Dietmar Rudolf Thal(Allen Institute for Brain Science), Mark Fiers(VIB-KU Leuven Center for Cancer Biology), Nicola Thrupp(VIB-KU Leuven Center for Brain & Disease Research), Katrien Horré(VIB-KU Leuven Center for Brain & Disease Research), Thomas K. Karikari(University of Pittsburgh), Iordana Chrysidou(VIB-KU Leuven Center for Brain & Disease Research), Evgenia Salta(Netherlands Institute for Neuroscience), Henrik Zetterberg(University of Wisconsin–Madison), Katleen Craessaerts(VIB-KU Leuven Center for Brain & Disease Research), Amaia M. Arranz(Ikerbasque), Wei-Ting Chen(Taipei Municipal YangMing Hospital), Joel Simrén(University of Gothenburg), An Snellinx(VIB-KU Leuven Center for Brain & Disease Research), Annerieke Sierksma(Vlaams Instituut voor Biotechnologie)
Cited by 216
Related Papers
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
|Neurology|2002|3.5k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
|Journal of Neuropathology & Experimental Neurology|2011|2.3k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k